The optimal timing of surgery in patients with resectable advanced ovarian cancer remains controversial. Should these patients receive the standard radical surgery followed by chemotherapy, or could ...
Neoadjuvant chemotherapy followed by interval cytoreductive surgery significantly improves survival rates in patients with advanced ovarian cancer compared with chemotherapy alone. Traditionally, ...
Martina Eckard, a 90-year-old Billings woman has survived both ovarian cancer and breast cancer. She now plans on leaving her ...
Patients with advanced ovarian cancer undergoing interval cytoreductive surgery who received paclitaxel-based hyperthermic intraperitoneal chemotherapy (HIPEC) during surgery appeared to have ...
9don MSN
Scientists develop an algorithm to measure the risk of ovarian cancer, delaying surgical menopause
The test is being made available to women at high risk of ovarian cancer in the UK through the National Health Service.
“Our goal is really to get out all the cancer,” says Dr. Arvind Bakhru. In the operating room, the gynecologic oncologist relies on sight and feel to help identify the cancerous lesions he’ll remove.
Sept. 12 -- FRIDAY, Sept. 11 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new test for women with pelvic tumors that are known to need surgery. The test, called OVA1, will ...
Several factors make ovarian cancer particularly challenging to treat. This is largely because the cancer often spreads at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback